Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGF Protein (AA 971-1023)

EGF Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant > 95 % by SDS-PAGE analysis. Active
N° du produit ABIN987814
  • Antigène Voir toutes EGF Protéines
    EGF (Epidermal Growth Factor (EGF))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    AA 971-1023
    Origine
    • 29
    • 17
    • 9
    • 4
    • 3
    • 1
    Humain
    Source
    • 34
    • 9
    • 8
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Attributs du produit
    ED50 <0.6 ng/mL, measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblasts in serum-free medium and CellTiter-Glo cell viability assay, corresponding to a specific activity of >1.7 x 10^6 units/mg.
    AA 971-1023, expressed with an N-terminal Met
    Pureté
    > 95 % by SDS-PAGE analysis.
    niveau d'endotoxine
    < 0.1 ng/μg (1 EU/μg) determined by LAL test
    Top Product
    Discover our top product EGF Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstituted in ddH2O at 100 μg/mL.
    Buffer
    Lyophilized after extensive dialysis against 10 mM PB, pH 7.0.
    Stock
    -80 °C
    Stockage commentaire
    Lyophilized recombinant human Epidermal Growth Factor (rhEGF) remains stable up to 12 months at -80 °C from date of receipt. Upon reconstitution, rhEGF should be stable up to 4 weeks at 4 °C or up to 6 months at -20 °C.
    Date de péremption
    12 months
  • Antigène
    EGF (Epidermal Growth Factor (EGF))
    Autre désignation
    Epidermal Growth Factor (EGF Produits)
    Synonymes
    HOMG4 Protein, URG Protein, AI790464 Protein, CEGF Protein, epidermal growth factor Protein, pro-epidermal growth factor Protein, EGF Protein, egf Protein, CpipJ_CPIJ020278 Protein, Egf Protein
    Sujet
    Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. Recombinant human Epidermal Growth Factor (rhEGF) produced in E. coli is a non-glycosylated polypeptide chain of 54 amino acids. A fully biologically active molecule, rhEGF has a molecular mass of 6.2 kDa analyzed by reducing SDS-PAGE.
    Synonyms: Urogastrone, URG
    Poids moléculaire
    6.2kDa, observed by reducing SDS-PAGE.
    Pathways
    Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Vous êtes ici:
Support technique